Skip to main content
Caplight Logo









Prolocor

Prolocor

Private
Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://prolocor.com/

Last Round

VC Round

Feb 27, 2024

Total Funding Raised

$5.2M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Prolocor is a biotechnology company that develops a precision diagnostic test designed to quantify platelet FcγRIIa to guide treatment decisions for cardiovascular disease.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Clinical Trials, Medical Devices

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

precision diagnosticsbiomarker assaycardiovascular risk assessmentflow cytometryantiplatelet therapythrombosiscompanion diagnosticsatherosclerotic cardiovascular diseaseclinical laboratorypersonalized medicinelab-developed testLDTblood testing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Prolocor Comparables

Compare Prolocor with similar companies based on industry and business-model similarity.

Prolocor comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Prevencio, Inc.
75%
Bio-MedPoint
71%
Werfen
67%

Prolocor Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundFeb 27, 2024
SeedAug 16, 2022
GrantAug 16, 2022

Key People

Founding team and executive leadership

Pete DiBattiste

President And CEO

Executive Team

Prolocor Investors

Notable investors and investment history

Prolocor investors
InvestorRounds
NIH RADxGrant
Green Park & Golf VenturesVC Round, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 22, 2026

    Monthly visitors increased 55% MoM.

  • Feb 27, 2024

    $1.7M round led by Green Park & Golf Ventures

Recent news

Latest coverage and updates

  • is_developingJul 20, 2026

    Prolocor Inc is developing Prolocor pFCG test on Jul 20th '26.

Prolocor Filings

Explore SEC and related filing metadata, where available.

Prolocor filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Prolocor's valuation, stock price, and market status.

Is Prolocor a public or private company?

Prolocor is a private company.

What is the current stock price of Prolocor?

Prolocor is a private company with no public stock price. No recent secondary market data is available.

How much is Prolocor worth (valuation)?

Valuation information for Prolocor is not publicly available.

Can I buy Prolocor stock?

Prolocor shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Prolocor's last funding round?

Prolocor's most recent funding round was Seed on February 27, 2024.

Who are the main investors in Prolocor?

Key investors in Prolocor include Green Park & Golf Ventures.

Will Prolocor IPO soon?

No public IPO plans have been announced for Prolocor.

How can I track Prolocor secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Prolocor's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Employee Range5
Year Founded2020
Last FundingFeb 27, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?